Delivery Order SPE2DB22D1106-SPE2DB24FEHA6
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the Corporate Office division of the for-profit parent company Cencora, Inc. (doing business as AmerisourceBergen). The contract is for the provision of 0.5 mL syringes of the pharmaceutical Phytonadione (Vitamin K1) 1 mg/0.5 mL. The potential value of the delivery order is $1,399.07, with a completion date of February 20, 2024. AmerisourceBergen Drug Corp also holds an...
- This federal contract award is for the delivery of phytonadione (vitamin K1) 1 mg/0.5 mL syrup in 0.5 mL vials to the Defense Logistics Agency (DLA). The $1,836.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 15, 2023, with a completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award SPE2DB20D3101|SPE2DB25FRBF5, with a ceiling value of $4,919.20, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 0.5 ml syringes containing 1 mg of phytonadione (vitamin K1) and has a completion date of February 7, 2025. This award is a delivery order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,811.29 delivery order contract is for the supply of Phytonadione 10 mg/mL ampoules, a type of injectable vitamin K medication. The contract is not set aside and is a firm fixed-price agreement with a performance period through June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1 mg/0.5 ml syringes of phytonadione, a medication used to treat vitamin K deficiency. The contract has a firm fixed price of $3,227.24 and a completion date of May 13, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,637.73 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, set to be completed by November 12, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used in medical settings...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,477.15 firm fixed-price delivery order is for the supply of 10 mg/mL phytonadione ampules, a medication used to treat vitamin K deficiency. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Phytonadione 1 mg/0.5 mL syrup, a Vitamin K medication, with a ceiling value of $11,567.66 and a performance period ending on August 27, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen, through its corporate office division, is the prime...
- The Defense Logistics Agency awarded a $6,754.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes with a completion date of December 8, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. Phytonadione,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,132.07 under firm fixed price terms. The delivery order is not set-aside and represents a competitively awarded procurement. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHA6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,708.42 firm fixed price delivery order is for the supply of 0.5 mL syringes containing 1 mg of phytonadione, a vitamin K supplement, to support military treatment programs and facilities. The award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to provide a broad range of pharmaceutical products and medical supplies to the Department of Defense. This IDC does not have any set-aside designations. The contract has a performance period through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 3/27/24 |